用HeartMate3进行左心室减压在心力衰竭中使用保存的喷射分数:虚拟拟拟合和血液动力学分析
Xiangyu He1, Moritz Bender1,2, Christoph Gross1
1From the Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.
概括
使用HeartMate 3设备的左心房减压显示出治疗心力衰竭的前景,使用保存的喷射分数 (HFpEF). 在体和体外研究表明,在HFpEF患者的解剖学兼容性和血液动力学疗效.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 医疗器械 医疗器械
背景情况:
- 保存喷射分数 (HFpEF) 的心力衰竭具有显著的未满足的临床需求.
- 之前对HFpEF的左心房减压的尝试因患者异质性和缺乏专门设备而受到阻碍.
研究的目的:
- 评估使用HeartMate 3 (HM3) 设备用于HFpEF患者左心房减压的可行性.
- 在HFpEF背景下评估HM3的解剖学兼容性和血液动力学有效性.
主要方法:
- 虚拟植入HM3设备到10名HFpEF患者的左心室通过左心室附属物 (LAA) 和左心室后壁 (LAPW).
- 使用混合模拟循环模拟休息和运动期间的HFpEF条件,对血液动力学有效性的实验研究.
主要成果:
- HM3显示出高度的解剖学兼容性,在90%的案例中通过LAA成功进行虚拟植入,在100%的案例中通过LAPW成功植入.
- 血液动力学分析显示,静止时左心房压力的正常化 (约. 在运动模拟过程中需要更高的速度 (6400-7400rpm).
结论:
- 用HM3装置进行左心房减压似乎对HFpEF患者在解剖学上是可行的.
- HM3 显示了 HFpEF 管理的潜在血动力学有效性,特别是在运动条件下.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Regurgitation III: Medical Management
18
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
18
Mitral Stenosis III: Medical Management
12
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure V: Medical Management
10
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
10
Aortic Regurgitation III: Medical Management
24
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24


